ImageneBio, Inc. (IMA)
NASDAQ: IMA · Real-Time Price · USD
5.25
-0.40 (-7.08%)
May 19, 2026, 4:00 PM EDT - Market closed

ImageneBio Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
-0.83.59.1615.6230.99
Revenue Growth (YoY)
--77.14%-61.79%-41.35%-49.59%237.01%
Gross Profit
-0.83.59.1615.6230.99
Selling, General & Admin
26.820.738.3924.9322.218.02
Research & Development
28.8228.5332.1159.6564.3247.11
Other Operating Expenses
0.31-----
Total Operating Expenses
55.9349.2540.584.5886.5265.12
Operating Income
-55.93-48.45-37-75.42-70.9-34.14
Interest Income
0.952.040.377.112.150.02
Other Non-Operating Income (Expense)
6.80.720.07-0.02-0.01-
Total Non-Operating Income (Expense)
10.532.750.457.092.140.02
Pretax Income
-45.4-45.7-36.56-68.33-68.77-34.12
Provision for Income Taxes
-0.1-0.350.010.16--
Net Income
-45.92-52.4-48.38-68.17-68.77-34.12
Net Income Attributable to Preferred Dividends
-13.25-7.05-11.82---
Net Income to Common
-45.92-52.4-48.38-68.17-68.77-34.12
Shares Outstanding (Basic)
855332
Shares Outstanding (Diluted)
855332
Shares Change (YoY)
244.40%-40.05%15.33%29.32%911.88%
EPS (Basic)
-4.24-9.64-22.10-19.60-22.80-14.64
EPS (Diluted)
-4.24-9.64-22.10-19.60-22.80-14.64
Shares Outstanding
11.2811.182.40.983.023
Free Cash Flow
-52.08-47.84-21.32-80.16-75.54-62.01
Free Cash Flow Per Share
-6.55-9.82-4.38-23.05-25.05-26.59
Gross Margin
-100.00%100.00%100.00%100.00%100.00%
Operating Margin
--6056.37%-1057.14%-823.33%-453.99%-110.18%
Profit Margin
--5668.63%-1044.80%-744.17%-440.29%-110.10%
FCF Margin
--5980.50%-609.11%-875.08%-483.67%-200.14%
EBITDA
-55.27-47.42-35.47-74.4-70.15-33.59
EBITDA Margin
--5927.25%-1013.54%-812.19%-449.18%-108.42%
EBIT
-55.93-48.45-37-75.42-70.9-34.14
EBIT Margin
--6056.37%-1057.14%-823.33%-453.99%-110.18%
Effective Tax Rate
0.22%0.77%-0.04%-0.24%0.00%0.00%
Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q